言語を選択
新規登録

TSLP R

TSLP R 詳細

英語名Thymic stromal lymphopoietin市販薬剤の数1
治験薬の数28ターゲットの別称Thymic stromal lymphopoietin，TSLP
研究＆開発段階Approved
英語名Thymic stromal lymphopoietin
ターゲットの別称Thymic stromal lymphopoietin，TSLP
市販薬剤の数1
治験薬の数28
研究＆開発段階Approved

TSLP R 製品リスト

  • 属性

    Protein (3)

  • 製品ライブラリ

    オンライン (3)

  • 種

    Human (2)Cynomolgus (1)

  • タグ

    Fc Tag (1)Fc Tag & Avi Tag (1)His Tag (1)

  • マーカー

    Unconjugated (2)Biotin-labeled (1)

製品番号種発現システム製品説明タンパク質の構造純度特性
TSR-H525a
Human
HEK293
Human TSLP R Protein, Fc Tag (MALS verified)
TSR-H82F3
Human
HEK293
Biotinylated Human TSLP R Protein, Fc,Avitag™
TSR-C52H3
Cynomolgus
HEK293
Cynomolgus TSLP R Protein, His Tag (MALS verified)
総数量3
  • 1
お問い合わせ

TSLP Rバックグランド

The encoded protein is a receptor for thymic stromal lymphopoietin (TSLP),TSLP binding to a heterodimeric receptor complex composed of IL-7Ralpha and the TSLP receptor (TSLPR) activate STAT3, STAT5, and JAK2 pathways, which plays an important role in the regulation of immune responses to allergens.

TSLP R分子の別称

TSLP R,CRLF2,IL-XR,ILXR,p2RY8,CRLF2 fusion,TSLP receptor,TSLPR,CRL2,CRLF2Y,Cytokine receptor-like 2

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
QL-2302QL2302; QL-2302Phase 3 ClinicalQilu Pharmaceutical Co LtdAsthma
詳細
GB-0895GB-0895Phase 3 ClinicalGenerate Biomedicines IncAsthma; Immune System Diseases; Pulmonary Disease, Chronic Obstructive
詳細
TilrekimigPF-07275315Phase 3 ClinicalPfizer IncAsthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
詳細
LunsekimigSAR-443765Phase 3 ClinicalSanofiAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Dermatitis, Atopic; Inflammation; Pulmonary Disease, Chronic Obstructive
詳細
BosakitugTQC-2731; BSI-045B; TQC2731; ATI-045Phase 3 ClinicalBiosion IncAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Dermatitis; Dermatitis, Atopic; Eczema; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Sinusitis
詳細
SHR-1905SHR-1905; AIO-001; GSK-5784283Phase 3 ClinicalJiangsu Hengrui Medicine Co LtdAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Dermatitis, Atopic; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Sinusitis
詳細
CM-326CM-326Phase 3 ClinicalKeymed Biosciences Co LtdAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Dermatitis, Atopic; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Sinusitis
詳細
QX-008NQX-008N; QX008N; JKN-2401; JKN2401; SNCA008; SNCA-008Phase 3 ClinicalQyuns Therapeutics Co LtdAsthma; Pulmonary Disease, Chronic Obstructive
詳細
SolrikitugNSI-8226; MK-8226Phase 2 ClinicalMerck & Co IncAsthma; Dermatitis, Atopic; Eosinophilic Esophagitis; Hypertension; Pulmonary Disease, Chronic Obstructive
詳細
EcleralimabCSJ-117; NOV-14Phase 2 ClinicalNovartis Pharma AgAsthma; Pulmonary Disease, Chronic Obstructive
詳細
HBM-9378HBM-9378; SKB378; SKB-378; A-378; WIN378; WIN-378Phase 2 ClinicalHarbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co LtdAsthma; Pulmonary Disease, Chronic Obstructive
詳細
CM-512CM512; CM-512Phase 2 ClinicalKeymed Biosciences Co LtdAsthma; Bronchiectasis; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Sinusitis
詳細
IBI-3002IBI3002; IBI-3002Phase 2 ClinicalAsthma; Dermatitis, Atopic
詳細
MG-ZG122MG-ZG122; MGZG122Phase 2 ClinicalShanghai Mabgeek Biotechnology Co LtdAsthma; Pulmonary Disease, Chronic Obstructive
詳細
AZD-8630AZD-8630; AMG-104Phase 2 ClinicalAmgen Inc, Astrazeneca PlcAsthma
詳細
TAVO-101TAVO-101; TAVO101Phase 2 ClinicalTavotek Biotherapeutics (Hong Kong) LtdDermatitis, Atopic; Hypersensitivity
詳細
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
詳細
APG273APG273; APG-273Phase 1 ClinicalApogee Therapeutics IncAsthma; Pulmonary Disease, Chronic Obstructive
詳細
HBM-7575HBM-7575; SKB575; SKB-575; HBM7575Phase 1 ClinicalHarbour BiomedDermatitis, Atopic; Inflammation
詳細
WIN-027QX027N; QX-027-N; WIN027; WIN-027Phase 1 ClinicalQyuns Therapeutics Co LtdAsthma; Dermatitis, Atopic
詳細
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co LtdAsthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive
詳細
APG-333APG333; APG-333; PR018; PR-018Phase 1 ClinicalApogee Therapeutics IncAsthma
詳細
SAR-444765SAR444765; SAR-444765Phase 1 ClinicalSanofiInflammation
詳細
BSI-502BSI-502; ATI-052Phase 1 ClinicalBiosion IncAutoimmune Diseases of the Nervous System; Inflammation
詳細
CDX-622CDX-622Phase 1 ClinicalCelldex Therapeutics IncAsthma; Fibrosis; Hypersensitivity; Inflammation
詳細
STSA-1201STSA-1201; STSA1201Phase 1 ClinicalStaidson(Beijing) Biopharmaceuticals Co LtdAsthma
詳細
LQ043HLQ043HPhase 1 ClinicalShanghai Novamab Biopharmaceuticals Co LtdAsthma
詳細
GR2002GR2002Phase 1 ClinicalGenrix (Shanghai) Biopharmaceutical Co LtdAsthma; Dermatitis, Atopic; Nasal Polyps; Sinusitis
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
TezepelumabMEDI-9929; AMG-157ApprovedAmgen IncTezspireUnited StatesAsthmaAstrazeneca Ab2021-12-17Anaphylaxis; Asthma; Bronchial Diseases; Carcinoma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Eosinophilic Esophagitis; Granulomatosis with Polyangiitis; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases; Lung Diseases; Lung Diseases, Obstructive; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; Respiratory Tract Diseases; Sinusitis
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8